Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01
Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01 Weekly Erlotinib for Familial Adenomatous Polyposis
Sponsor: National Cancer Institute (NCI)
This observational or N/A phase trial investigates Familial Adenomatous Polyposis and is currently completed. National Cancer Institute (NCI) leads this study, which shows 8 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jul 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Feb 2022 — Jul 2022 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Nov 2021 — Feb 2022 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Sep 2021 — Nov 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
May 2021 — Sep 2021 [monthly]
Not Yet Recruiting
-
Jan 2021 — May 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .